This site is intended for healthcare professionals
News

Pooled data from phase III studies TRuE-AD1 and TRuE-AD2 of Jakavi shows itch reduction in atopic dermatitis.- Incyte

Read time: 1 mins
Last updated:30th Oct 2020
Published:30th Oct 2020
Condition: Atopic Dermatitis (Eczema)
Type: drug
Register free for full access to medthority.com